Stockscreener 앱 받기
226.44
2.88%
6.33
시간 외 거래:
234.80
8.36
+3.69%
Natera Inc 주식(NTRA)의 최신 뉴스
Natera expands Austin operations with new sequencing facility - MSN
Natera to launch enhanced Panorama NIPT for low fetal fractions - MSN
Forget SpaceX Hype: Billionaire Stanley Druckenmiller is Loading Up on This Unknown Healthcare Stock - Insider Monkey
Morgan Stanley files Form 144 for 100,000 NTRA shares (NASDAQ: NTRA) - Stock Titan
Natera Inc Stock (US6323071042): Analyst calls from RBC and Goldman put diagnostics specialist in fo - AD HOC NEWS
Natera MRD Leadership Supported by 'Durable' High-Value Market, RBC Says - Moomoo
NTRA & Diakonos partner to use Signatera in refractory melanoma trial - MSN
RBC Capital Maintains Natera(NTRA.US) With Buy Rating, Cuts Target Price to $275 - Moomoo
RBC Capital initiates Natera stock coverage with outperform rating By Investing.com - Investing.com Australia
RBC Capital initiates Natera stock coverage with outperform rating - Investing.com
Natera (NTRA) Coverage Resumed with Positive Outlook and Price T - GuruFocus
NTRA & CytoDyn partner to advance ctDNA-guided development in mCRC - MSN
Natera director Marcus Boxer sells $2.39 million in stock - Investing.com UK
Natera director Marcus Boxer sells $2.39 million in stock By Investing.com - Investing.com South Africa
Natera (NTRA) director Boxer exercises options and sells 11,000 shares - Stock Titan
Natera : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
Thomas J. Lynch Jr. joins Natera (NTRA) insider list with Form 3 filing - Stock Titan
Have Natera Insiders Been Selling Stock? - simplywall.st
NTRA & CytoDyn Partner to Advance ctDNA-Guided Development in mCRC - Yahoo Finance
Natera Pushes MRD And Panorama Into Treatment Guiding Roles - Yahoo Finance
Billionaire Stanley Druckenmiller Likes This Cancer Stock - Insider Monkey
How Investors May Respond To Natera (NTRA) Expanding Signatera MRD Reach Amid Insider Share Sale - simplywall.st
Natera, Inc. (NTRA) Stock Analysis: Insights into a High-Growth Diagnostics Leader with a 20% Upside Potential - DirectorsTalk Interviews
This Insider Has Just Sold Shares In Natera - Moomoo
Net income of Natera, Inc. – XETR:45E - TradingView
Assessing Natera (NTRA) Valuation After Strong Multi Year Returns And Recent Share Price Cooling - simplywall.st
5 Healthcare Stocks That the AI Crowd Is Overlooking - Barron's
Natera, Inc. Balance Sheet – XETR:45E - TradingView
Goldman Sachs Initiates Natera(NTRA.US) With Hold Rating, Announces Target Price $245 - Moomoo
Natera's EXPAND trial enrollment crosses 2,000 patient milestone - MSN
Insider Sell Alert: Steven Chapman Sells 41,124 Shares of Natera Inc (NTRA) - GuruFocus
Natera CEO Steven Chapman sells $9.09 million in company stock By Investing.com - Investing.com South Africa
Natera CEO Steven Chapman sells $9.09 million in company stock - Investing.com UK
Natera(NTRA.US) Officer Sells US$9.09 Million in Common Stock - Moomoo
Natera (NTRA) CEO Chapman sells 41,124 shares under 10b5-1 plan - Stock Titan
(NTRA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
[144] Natera, Inc. SEC Filing - Stock Titan
Natera Expands Board, Appoints Thomas Lynch as Director - TipRanks
Natera (NTRA) appoints independent director Thomas Lynch and expands board - Stock Titan
Natera executive chairman sells $1.64m in shares - Investing.com
NTRA Initiates Coverage On Goldman Sachs -- Rating Set to Neutra - GuruFocus
Natera, Inc. Earnings and Revenue – XETR:45E - TradingView
Goldman Sachs initiates Natera stock with Neutral rating, $245 target - Investing.com UK
Goldman Sachs initiates Natera stock with Neutral rating, $245 target By Investing.com - Investing.com Australia
0.98%
자본화:
|
볼륨(24시간):